Early renal denervation prevents development of hypertension in growth-restricted offspring

Norma B Ojeda1, W Russell Johnson, Terry M Dwyer

  • 1Department of Physiology, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Insights

Renal nerves play a causative role in the early development of hypertension in intrauterine growth-restricted (IUGR) offspring. Denervation significantly reduced blood pressure in IUGR rats, indicating their involvement in the condition

Area of Science:

  • Nephrology
  • Developmental Biology
  • Cardiovascular Physiology

Background:

  • Low birth weight and intrauterine growth restriction (IUGR) are linked to hypertension development.
  • IUGR offspring develop hypertension prepubertally, with males remaining hypertensive post-puberty.
  • Renal nerves are implicated in maintaining established hypertension in adult male IUGR offspring.

Purpose of the Study:

  • To investigate the causative role of renal nerves in the early development of IUGR-induced hypertension.
  • To determine if renal nerves contribute to hypertension in prepubertal IUGR offspring.

Main Methods:

  • Intrauterine growth-restricted (IUGR) and control rat offspring underwent bilateral renal denervation or sham surgery at 4 weeks of age.
  • Mean arterial pressure (MAP) was measured at 6 weeks of age in conscious, instrumented animals.
  • Renal noradrenaline content was assessed to confirm denervation efficacy.

Main Results:

  • Renal denervation did not affect MAP in control offspring.
  • Renal denervation significantly reduced MAP in IUGR offspring (114 ± 3 vs 104 ± 1 mmHg, P < 0.01).
  • Reduced renal noradrenaline confirmed successful denervation in treated animals.

Conclusions:

  • Renal nerves play a significant role in the etiology of IUGR-induced hypertension.
  • The findings suggest renal nerves contribute to the early development of hypertension in IUGR offspring.
  • This adds to the known role of renal nerves in maintaining established hypertension in adult IUGR males.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...